BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12075381)

  • 21. [Diagnosis and development of heparin-induced thrombocytopenia. Biological and clinical aspects].
    Elalamy I; Page Y; Viallon A; Tardy B; Conard J; Helft G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):961-74. PubMed ID: 10907445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
    Januzzi JL; Jang IK
    J Thromb Thrombolysis; 1999 Jun; 7(3):259-64. PubMed ID: 10375387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin induced thrombocytopenia: diagnosis and management update.
    Ahmed I; Majeed A; Powell R
    Postgrad Med J; 2007 Sep; 83(983):575-82. PubMed ID: 17823223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
    Lassila R; Antovic JP; Armstrong E; Baghaei F; Dalsgaard-Nielsen J; Hillarp A; Holme PA; Holmström M; Johnsson H; Joutsi-Korhonen L; Sandset PM
    Semin Thromb Hemost; 2011 Apr; 37(3):328-36. PubMed ID: 21455867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Hassell K
    Chest; 2005 Feb; 127(2 Suppl):1S-8S. PubMed ID: 15706025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery.
    Pouplard C; Regina S; May MA; Gruel Y
    Arch Mal Coeur Vaiss; 2007; 100(6-7):563-8. PubMed ID: 17893639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 31. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
    Höhnke C; Haas S
    Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
    Darling K; Jaumotte C; Saussoy P; Zech F; Lavenne E; Hainaut P
    Acta Clin Belg; 2000; 55(3):176-81. PubMed ID: 10981327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 36. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
    Prechel M; Walenga JM
    Semin Thromb Hemost; 2008 Feb; 34(1):86-96. PubMed ID: 18393145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current status of anticoagulants].
    Oger E; Mottier D
    Presse Med; 2000 May 27-Jun 3; 29(19):1079-82. PubMed ID: 10874921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparin-induced thrombopenia].
    de Maistre E; Wahl D; Briquel ME; André E; Lecompte T
    Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):37-41. PubMed ID: 12555357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
    Wilde MI; Markham A
    Drugs; 1997 Dec; 54(6):903-24. PubMed ID: 9421696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lepirudin use in a neonate with heparin-induced thrombocytopenia.
    Nguyen TN; Gal P; Ransom JL; Carlos R
    Ann Pharmacother; 2003 Feb; 37(2):229-33. PubMed ID: 12549954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.